Abstract
Both epidemiological and experimental evidence is accumulating to show that a lignan-rich diet may reduce the risk of human breast cancer (BC). High serum and urine concentrations of enterolactone (ENL) have been correlated with a reduced risk of BC, and further, the anticarcinogenic effects of lignans have been demonstrated in animal models. This has raised considerable interest in health effects of lignans. Because of the limited supply of pure lignans and lack of toxicological data, however, no clinical trials have so far been conducted in effort to assess the anticarcinogenic effects of lignans in humans. Moreover, the mechanisms of their possible anticarcinogenic effects remain obscure.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adlercreutz, H., Bannwart, C, Wahala, K., Makela, T., Brunow, G., Hase, T., Arosemena, P.J., Kellis, J.T. and Vickery, L.E. (1993b) Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol., 44 (2), 147–153.
Cohen, L.A., Polansky, M., Furuya, K., Reddy, M., Berke, B. and Weisburger, J.H. (1984) Inhibition of chemically induced mammary carcinogenesis in rats by short-term exposure to butylated hydroxytoluene (BHT): Interrelationships among BHT concentration, carcinogen dose, and diet. J Natl Cancer Inst., 72 (1), 165–174.
Hulten, K., Winkvist, A., Lenner, P., Johansson, R., Adlercreutz, H. and Hallmans, G. (2002) An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 41 (4): 168–176.
Ingram, D., Sanders, K., Kolybaba, M. and Lopez D. (1997) Case-control study of phytoestrogens and breast cancer, Lancet 350 (9083), 990–994.
Jordan, V,C., Mittal, S., Gosden, B., Koch, R. and Lieberman, M.E. (1985). Structure-activity relationship of estrogens. Environ Health Perspec., 61, 97–110.
Pietinen, P., Stumpf, K., Mannisto, S., Kataja, B., Uusitupa, M. and Adlercreutz H. (2001) Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland, Cancer Epidemiol Biomarkers Prev. 10 (4), 339–344.
Saarinen, N.M., Huovinen, R., Wärri, A., Mäkelä, S.I., Valentin-Blasini, L., Needham, L., Eckerman, C., Collan, Y.U. and Santti, R. (2001) Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model. Nutr Cancer, 41 (1 and2), 82–90.
Saarinen, N.M., Huovinen, R., Wärri, A., Mäkelä, S.I., Valentin-Biasini, L., Sjöholm, R., Ämmälä, J., Lehtilä, R., Eckerman, C., Collan, Y.U. and Santti, R.S. (2002) Enterolactone inhibits the growth of 7,12- dimethylbenz[a]anthracene-induced mammary carcinomas in the rat. Mol Cancer Ther., 1, 869–876.
Saarinen, N.M., Wärri, A., Mäkelä, S.I., Eckerman, C., Reunanen, M., Ahotupa, M., Salmi, S.M., Franke, A.A., Kangas, L., and Santti, R. (2000) Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer, 36 (2), 207–216.
Sporn, M.B. and Suh, N. (2002) Chemoprevention: an essential approach to controlling cancer. Nature Reviews 2, 537543.
Thompson, L.U., Chen, J. and Goss, P.E. (2000) Biological effects of dietary flaxseed in patients with breast cancer. Breast Cancer Res Treat., 64, 50
Thompson, L.U., Rickard, S.E., Orcheson, L.J. and Seidl, M.M. (1996a) Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis, 17 (6), 1373–1376.
Thompson, L.U., Seidl, M.M., Rickard, S.E., Orcheson, L.J. and Fong, H.H. (1996b) Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer, 26 (2), 159–165.
den Tonkelaar, I., Keinan-Boker, L., Veer, P.V., Arts, C.J., Adlercreutz, H., Thijssen, J.H. and Peeters, P.H. (2001) Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 10 (3): 223–228.
Wang C, Mäkelä T, Hase T, Adlercreutz H, and Kurzer M.S. (1994) Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol., 50 (3–4), 205–212.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Saarinen, N., Mäkelä, S., Santti, R. (2003). Anticancer Effects of Lignans. In: Yagasaki, K., Miura, Y., Hatori, M., Nomura, Y. (eds) Animal Cell Technology: Basic & Applied Aspects. Animal Cell Technology: Basic & Applied Aspects, vol 13. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0726-8_10
Download citation
DOI: https://doi.org/10.1007/978-94-017-0726-8_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6557-5
Online ISBN: 978-94-017-0726-8
eBook Packages: Springer Book Archive